@article{1987df1c8c5549639a9449969eb686b9,
title = "Reply to: “The First Allogeneic Hematopoietic Stem Cell Transplantation in a Polish Patient with Adult-Onset Leukoencephalopathy with Spheroids and Pigmented Glia”",
keywords = "CSF1R-related leukoencephalopathy, stem cell transplantation, treatment",
author = "Tipton, {Philip W.} and Wierenga, {Klaas J.} and Wszolek, {Zbigniew K.}",
note = "Funding Information: Z.K.W. is partially supported by the NIH/NIA and NIH/NINDS (1U19AG063911, FAIN: U19AG063911), the Mayo Clinic Center for Regenerative Medicine, the Mayo Clinic in Florida Focused Research Team Program, the gifts from the Donald G. and Jodi P. Heeringa Family, the Haworth Family Professorship in Neurodegenerative Diseases fund, the Albertson Parkinson's Research Foundation, and the Ann B. Smith Research Fund. He serves as principal investigator or co‐prinicipal investigator for Biohaven Pharmaceuticals, Inc. (BHV4157‐206 and BHV3241‐301); Neuraly, Inc. (NLY01‐PD‐1); and Vigil Neuroscience, Inc. (VGL101‐01.001 and VGL101‐01.002). He serves as co‐principal investigator for the Mayo Clinic APDA Center for Advanced Research and as an external advisory board member for Vigil Neuroscience, Inc. ",
year = "2022",
month = jul,
doi = "10.1002/mds.29065",
language = "English (US)",
volume = "37",
pages = "1572--1573",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "7",
}